DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Plaque/ Luciferase assay are 2




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_5596Sunitinib
Antineoplastic and Immunomodulating Agents
Renal cell carcinoma | Gastrointestinal stromal tumor
Dengue virus
TSV01, 429557, New Guinea C
Pathway
Plaque/ Luciferase assay
Decrease (50 %)
Approved, Investigational
28240606
DrugRepV_5597Erlotinib
Antineoplastic and Immunomodulating Agents
Cancer
Dengue virus
TSV01, 429557, New Guinea C
Pathway
Plaque/ Luciferase assay
Decrease (50 %)
Approved
28240606